PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle - - GEO DataSets

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle

Analysis of skeletal muscle from obese women with polycystic ovary syndrome (PCOS) before and after thiazolidinedione (TZD) pioglitazone treatment. TZDs improve metabolic disturbances in PCOS patients. Results provide insight into the molecular mechanisms underlying the effect of TZD in PCOS.

Organism:: Homo sapiens

Type:: Expression profiling by array, count, 2 agent sets

Platform:: GPL570
Series:: GSE8157
20 Samples

Download data: CEL

DataSet

Accession:: GDS4132

ID:: 4132

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

GEO DataSets

Functional Genomics Studies

Result Filters

Send to:

Links from GEO Profiles

Supplemental Content

Related information

Important Links

Recent activity